Beyond the hype

anonymous

Guest
Hear you go, from the NYT:

“This place is a total joke. It's barely a pharmaceutical product. It's makes much more sens to buy over the counter fish oil for the same results. The company has one "product" and ZERO pipeline. Management is sitting around until 2018, hoping their study will lead to a buyout by a larger company. The fact that there a reps pushing fish oil is comical. If you're a Amarin DM, it's even more embarrassing. What a negative on the resume builder.”
 






Also from the NYT in 2015:

“The US economic climate is bleak. Stocks are down to record levels with no growth in sight and the bull market has finally ended. The bear market is beginning and it’s going to get very, very, ugly, many are saying even worse than 2008.”

MmmmmmK. I’m just gonna leave that right there kids.
 






Hear you go, from the NYT:

“This place is a total joke. It's barely a pharmaceutical product. It's makes much more sens to buy over the counter fish oil for the same results. The company has one "product" and ZERO pipeline. Management
is sitting around until 2018, hoping their study will lead to a buyout by a larger company. The fact that there a reps pushing fish oil is comical. If you're a Amarin DM, it's even more embarrassing. What a negative on the resume builder.”




So the NYT suffers from the same obnoxious underlined font, spelling errors and horrible sentence structure as this message boards famous troll poster? Irony so thick you can cut through it with a butter knife...
 






From the Pink Sheet:

it’s a food supplement not a pharmaceutical hence will be approved as an otc direct to consumer product commonly sold in grocery store next to the frozen fish refrigerator and funnel cakes, also look out for discount coupons in the Sunday news papers.”
So the NYT suffers from the same obnoxious underlined font, spelling errors and horrible sentence structure as this message boards famous troll poster? Irony so thick you can cut through it with a butter knife...